226 related articles for article (PubMed ID: 25874654)
1. The economic impact of moderate stage Alzheimer's disease in Italy: evidence from the UP-TECH randomized trial.
Chiatti C; Furneri G; Rimland JM; Demma F; Bonfranceschi F; Cassetta L; Masera F; Cherubini A; Corsonello A; Lattanzio F;
Int Psychogeriatr; 2015 Sep; 27(9):1563-72. PubMed ID: 25874654
[TBL] [Abstract][Full Text] [Related]
2. The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: preliminary findings on recruitment and caregiving burden in the baseline population.
Chiatti C; Rimland JM; Bonfranceschi F; Masera F; Bustacchini S; Cassetta L; ;
Aging Ment Health; 2015; 19(6):517-25. PubMed ID: 25188811
[TBL] [Abstract][Full Text] [Related]
3. The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: study protocol for a randomized controlled trial.
Chiatti C; Masera F; Rimland JM; Cherubini A; Scarpino O; Spazzafumo L; Lattanzio F;
Trials; 2013 May; 14():155. PubMed ID: 23714287
[TBL] [Abstract][Full Text] [Related]
4. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
[TBL] [Abstract][Full Text] [Related]
5. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic Predictors of the Employment of Migrant Care Workers by Italian Families Assisting Older Alzheimer's Disease Patients: Evidence From the Up-Tech Study.
Barbabella F; Chiatti C; Rimland JM; Melchiorre MG; Lamura G; Lattanzio F;
J Gerontol B Psychol Sci Soc Sci; 2016 May; 71(3):514-25. PubMed ID: 26297707
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.
Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jönsson L
Int Psychogeriatr; 2011 Feb; 23(1):73-85. PubMed ID: 20619068
[TBL] [Abstract][Full Text] [Related]
8. The TECH@HOME study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia: study protocol for a randomized controlled trial.
Malmgren Fänge A; Schmidt SM; Nilsson MH; Carlsson G; Liwander A; Dahlgren Bergström C; Olivetti P; Johansson P; Chiatti C;
Trials; 2017 Feb; 18(1):63. PubMed ID: 28183323
[TBL] [Abstract][Full Text] [Related]
9. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
[TBL] [Abstract][Full Text] [Related]
10. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
[TBL] [Abstract][Full Text] [Related]
11. The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy.
Cavallo MC; Fattore G
Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):184-90. PubMed ID: 9437435
[TBL] [Abstract][Full Text] [Related]
12. An Analysis of the Public Financial Support Eligibility Rule for French Dependent Elders with Alzheimer's Disease.
Rapp T; Lacey L; Ousset PJ; Cowppli-Bony P; Vellas B; Orgogozo JM
Value Health; 2015 Jul; 18(5):553-9. PubMed ID: 26297082
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
[TBL] [Abstract][Full Text] [Related]
14. Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
Tahami Monfared AA; Khachatryan A; Hummel N; Kopiec A; Martinez M; Zhang R; Zhang Q
J Alzheimers Dis; 2024; 99(1):191-206. PubMed ID: 38640156
[TBL] [Abstract][Full Text] [Related]
15. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
[TBL] [Abstract][Full Text] [Related]
16. Cost of informal care for community-dwelling mild-moderate dementia patients in a developed Southeast Asian country.
Chong MS; Tan WS; Chan M; Lim WS; Ali N; Ang YY; Chua KC
Int Psychogeriatr; 2013 Sep; 25(9):1475-83. PubMed ID: 23694676
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: usefulness of the Family Strain Questionnaire and the Screen for Caregiver Burden in the study of caregiving-related problems.
Ferrario SR; Vitaliano P; Zotti AM; Galante E; Fornara R
Int J Geriatr Psychiatry; 2003 Dec; 18(12):1110-4. PubMed ID: 14677143
[TBL] [Abstract][Full Text] [Related]
18. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
[TBL] [Abstract][Full Text] [Related]
19. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
[TBL] [Abstract][Full Text] [Related]
20. Determinants of societal costs in Alzheimer's disease: GERAS study baseline results.
Dodel R; Belger M; Reed C; Wimo A; Jones RW; Happich M; Argimon JM; Bruno G; Vellas B; Haro JM
Alzheimers Dement; 2015 Aug; 11(8):933-45. PubMed ID: 25846298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
